209 related articles for article (PubMed ID: 15313848)
1. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
[TBL] [Abstract][Full Text] [Related]
2. Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):2S-5S. PubMed ID: 12198366
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the CCK, CCKAR and CCKBR genes: an association with alcoholism study.
Okubo T; Harada S
J Stud Alcohol; 2001 Jul; 62(4):413-21. PubMed ID: 11513220
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
[TBL] [Abstract][Full Text] [Related]
5. Gene variations in the cholecystokinin system in patients with panic disorder.
Koefoed P; Woldbye DP; Hansen TO; Hansen ES; Knudsen GM; Bolwig TG; Rehfeld JF
Psychiatr Genet; 2010 Apr; 20(2):59-64. PubMed ID: 20023595
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
Goetz CG; Burke PF; Leurgans S; Berry-Kravis E; Blasucci LM; Raman R; Zhou L
Arch Neurol; 2001 Feb; 58(2):209-13. PubMed ID: 11176958
[TBL] [Abstract][Full Text] [Related]
7. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
Wang J; Liu Z; Chen B
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
[TBL] [Abstract][Full Text] [Related]
8. Association between CCK-AR gene and schizophrenia with auditory hallucinations.
Toirac I; Sanjuán J; Aguilar EJ; González JC; Artigas F; Rivero O; Nájera C; Moltó MD; de Frutos R
Psychiatr Genet; 2007 Apr; 17(2):47-53. PubMed ID: 17413443
[TBL] [Abstract][Full Text] [Related]
9. Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
Kiferle L; Ceravolo R; Petrozzi L; Rossi C; Frosini D; Rocchi A; Siciliano G; Bonuccelli U; Murri L
Neurosci Lett; 2007 Jul; 422(3):228-31. PubMed ID: 17614196
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior.
Takimoto T; Terayama H; Waga C; Okayama T; Ikeda K; Fukunishi I; Iwahashi K
Psychiatry Res; 2005 Feb; 133(2-3):123-8. PubMed ID: 15740988
[TBL] [Abstract][Full Text] [Related]
12. [Association between estrogen receptor beta gene polymorphisms and Parkinson disease].
Chen RJ; Zhang BS; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1185-8. PubMed ID: 18844113
[TBL] [Abstract][Full Text] [Related]
13. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
[TBL] [Abstract][Full Text] [Related]
14. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
[TBL] [Abstract][Full Text] [Related]
15. Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia.
Tachikawa H; Harada S; Kawanishi Y; Okubo T; Suzuki T
Psychiatry Res; 2001 Sep; 103(2-3):147-55. PubMed ID: 11549403
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
17. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.
Zheng K; Heydari B; Simon DK
Arch Neurol; 2003 May; 60(5):722-5. PubMed ID: 12756136
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
[TBL] [Abstract][Full Text] [Related]
20. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
de la Fuente-Fernández R; Núñez MA; López E
Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
